INmune Bio's XPro1595 targets soluble TNF for Alzheimer's. Phase 2 results could reshape inflammatory disease treatment.

Wyndham Hotels faces headwinds as US RevPAR declines and leisure demand softens, despite strong growth prospects. Learn more ...

The MoneyShow Chart of the Day shows the performance of the Energy Select Sector SPDR Fund (XLE) over the past 12 months. We ...

Discover why Tonix Pharmaceuticals Holding Corp. stock could rally with FDA approval for Tonmya targeting fibromyalgia. Click ...

Read why DNOW's strong balance sheet and diversification mitigate risks but global uncertainty and tariffs keep it a Hold.

Dollar General's turnaround shines with improved margins, new customer growth, and debt reduction. Read why I think DG stock ...

Discover how NDIA and INDE ETFs differ in strategies, costs, and performance. Learn which offers better valuations and ...

Discover why BeOne Medicines (BEIGF) is a strong Buy with growth driven by Brukinsa, Tevimbra, and a promising oncology ...

Global X U.S. Preferred ETF offers diversified preferred securities exposure with a $2.28B portfolio, low fees, and ...

Cantaloupe (CTLP) entered into a definitive agreement to be acquired by 365 Retail Markets, a provider of unattended retail ...

Boeing stock strongly outperformed the S&P 500 in 2024 driven by robust airplane orders and improving production stability.

The new order will expand the fleets of both All Nippon Airways (ANA) and its low-cost subsidiary Peach Aviation. ANA will ...